Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2008
09/18/2008WO2008074832A3 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase ( scd)
09/18/2008WO2008063232B1 Substituted pyrazolopyrimidines
09/18/2008WO2008061112A9 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
09/18/2008US20080227981 Charge transport compositions and electronic devices made with such compositions
09/18/2008US20080227826 Such as (S)-2-(Dimethylamino)ethyl-1-(4-(2-aminophenylcarbamoyl)-phenyl)pyrrolidin-3-ylcarbamate for treating cell proliferative disorders
09/18/2008US20080227823 (E)-4-(3-(3-bromo-4-fluorophenyl)acrylamido)-N-(2-(5-fluoro-1H-indol-3-yl)ethyl)piperidine-4-carboxamide; ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted T-type calcium channel activity
09/18/2008US20080227821 N-substituted tricyclic 3-aminopyrazoles as anti-mitotic tubulin polymerization inhibitors
09/18/2008US20080227820 cis-6-Fluoro-1-{[1-(4-fluorophenyl)-1H-indazol-4-yl]amino}-1,2,3,4-tetrahydro-5-methoxy-4,4-dimethyl-6-(trifluoromethyl)naphthalene-2-ol; selectivity towards the glucocorticoid receptor (GR) is improved compared to the other steroid receptors
09/18/2008US20080227814 Ethanolamine derivatives such as 6-hydroxy-1-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-(p-methylsulfonylphenyl)tetralin and 6-hydroxy-2-(p-(trifluoromethyl)phenyl)-3-(p-(2-(1-piperidinyl)ethoxy)benzoyl)benzothiophene; treating endometriosis and uterine leiomyoma.
09/18/2008US20080227810 6-Cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
09/18/2008US20080227799 treating or reducing the severity of hyperproliferative diseases by inhibiting metastasis
09/18/2008US20080227798 inhibiting dipeptidyl peptidases; diabetes mellitus
09/18/2008US20080227794 Metabotropic Glutamate-Receptor-Potentiating Isoindolones
09/18/2008US20080227793 2-(1-Imidazomethyl)- or 2-(1-imidazooxy)-substituted, e.g., 6-chloro-2-{[2-(2-fluorophenyl)-1H-imidazol-1-yl]methyl}-1-propyl1H-benzimidazole; GABA receptor signal transduction; anxiety, antidepressants, sleep disorders, schizophrenia, attention deficit-hyperactivity disorder, memory enhancement
09/18/2008US20080227792 3,4-Dihydro-1H-Isoquinoline-2-Carboxylic Acid 5-Aminopyridin-2-Yl Esters
09/18/2008US20080227791 treating or preventing central nervous system disorders, for example schizophrenia, by exerting an antipsychotic effect without motor side effects; N-[1-(4-fluorobenzyl)piperidin-4-yl]-6-(trifluoromethyl)pyridazin-3-amine
09/18/2008US20080227790 treating an airway disorder; 4-(3-{3,4-dimethoxyphenyl}-5,5-dimethyl-6-oxo-5,6-dihydro-4H-pyridazin-1-yl)-benzoic acid
09/18/2008US20080227785 BEC 1 potassium channel inhibitors, used to treat dementia and learning disorders; e.g., N-(4-fluorophenyl)-N'-isopropyl-N''-phenyl-1,3,5-triazine-2,4,6-triamine hydrochloride
09/18/2008US20080227782 Pyrimidine amide compounds as pgds inhibitors
09/18/2008US20080227781 Imidazole compounds for the treatment of neurodegenerative disorders
09/18/2008US20080227778 6-Methoxy-3-(methoxymethyl)-2-methyl-4-phenylisoquinolin-1(2H)-one; treat cardiac arrhythmias
09/18/2008US20080226618 Hydantoin derivatives useful as antibacterial agents
09/18/2008US20080226559 Benztropine Compounds and Uses Thereof
09/18/2008DE102007012284A1 Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel New substituted Arylsulfonylglycine, their preparation and their use as medicaments
09/18/2008CA2709220A1 Spiro substituted compounds as angiogenesis inhibitors
09/18/2008CA2702650A1 Phenyl amino pyrimidine compounds and uses thereof
09/18/2008CA2681162A1 Benzyl and pyridine derivatives as modulators of hedgehog pathway
09/18/2008CA2681118A1 Amide derivatives as calcium channel blockers
09/18/2008CA2681005A1 Spiro substituted compounds as angiogenesis inhibitors
09/18/2008CA2680796A1 Inhibitors of the hedgehog pathway
09/18/2008CA2680467A1 Inhibitors of histone deacetylase
09/18/2008CA2680412A1 Piperidinones useful in the treatment of inflammation
09/18/2008CA2680366A1 Inhibitors of carnitine palmitoyltransferase and treating cancer
09/18/2008CA2680360A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
09/18/2008CA2679714A1 Quinoline derivatives as fungicides
09/17/2008EP1970375A1 Arylmethylene urea derivative and use thereof
09/17/2008EP1970374A1 Process for the production of substituted 2-(pyridin-2-ylmethylsulfinyl)-1H-benzimidazoles
09/17/2008EP1970373A1 Alicyclic heterocyclic compound
09/17/2008EP1968970A2 Processes for the preparation of alfuzosin
09/17/2008EP1968969A2 Organic compounds
09/17/2008EP1968968A1 Compositions and methods for modulating gated ion channels
09/17/2008EP1968967A1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators
09/17/2008EP1968962A2 Diaza heterocyclic sulfonamide derivatives and their uses
09/17/2008EP1968947A1 Gaba-b receptor modulators
09/17/2008EP1968945A2 Muscarinic receptor antagonists
09/17/2008EP1968941A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp)
09/17/2008EP1968940A1 3 , 5-substitued piperidine compounds as renin inhibitors
09/17/2008EP1968938A1 Substituted propiolic acid amides and their use for producing drugs
09/17/2008EP1968935A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments
09/17/2008EP1828164B1 Method for preparing n-phenylpyrazole-1-carboxamides
09/17/2008EP1776356B1 Alkyl-and piperidine-substituted benzimidazole-derivates
09/17/2008EP1732892B1 Tetrahydrocarbazoles and derivatives
09/17/2008EP1495003B1 Fredericamycin derivatives
09/17/2008EP1490067B1 Use of tyrosine kinase inhibitors for treating substance use disorders
09/17/2008EP1447400B1 Bicyclic compound
09/17/2008EP1409477B1 Piperidine derivatives as nmda receptor antagonists
09/17/2008EP1325910B1 Aliphatic nitrogenous five-membered ring compounds
09/17/2008EP1202736B1 Nicotine in therapeutic angiogenesis and vasculogenesis
09/17/2008CN101268064A Pyrazine derivatives useful as adenosine receptor antagonists
09/17/2008CN101268059A 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides
09/17/2008CN101268058A 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
09/17/2008CN101268051A Isotopically substituted proton pump inhibitors
09/17/2008CN101268050A Isotopically substituted pantoprazole
09/17/2008CN101268048A Carbazole derivatives
09/17/2008CN101268043A Amino-alkyl-amide derivatives as CCR3 receptor ligands
09/17/2008CN100418982C Lomefloxacin conjugate and its preparing method and use
09/17/2008CN100418955C Novel Benzo-fused heterocycles
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/17/2008CN100418526C Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
09/17/2008CN100418525C Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
09/16/2008US7425639 Process
09/16/2008US7425638 Cis-imidazolines
09/16/2008US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent
09/16/2008US7425634 Benzimidazole compound
09/16/2008US7425633 (3S,5S)-5-(pyrrolidine-1-carbonyl)-N-((1S,2R)-2-(3-(trifluoromethyl)phenyl)cyclopropyl)pyrrolidine-3-carboxamide; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
09/16/2008US7425630 Processes for preparing pyrazolo[3,4-d]pyrimidine ethers
09/16/2008US7425570 Pyridoxine and pyridoxal analogues: new uses
09/16/2008US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
09/16/2008US7425564 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus prolifertor receptor and medicinal composition containing the same
09/16/2008US7425563 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline
09/16/2008US7425559 Medicine containing pyrimidine derivative
09/16/2008US7425557 Inhibitors of glycogen synthase kinase 3
09/16/2008US7425550 Lactam glycogen phosphorylase inhibitors and method of use
09/16/2008US7425451 Sequestering proteins, peptides; determination concentration in mixture; analyzing by mass spectroscopy
09/16/2008CA2515338C Inhibitors of histone deacetylase
09/16/2008CA2427221C Process and intermediates for preparing anti-cancer compounds
09/16/2008CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
09/12/2008WO2008109702A1 Compounds and compositions as modulators of gpr119 activity
09/12/2008WO2008109700A1 Ppar active compounds
09/12/2008WO2008109336A1 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor
09/12/2008WO2008109333A1 Indole and benzothiophene compounds as modulators of the histamine h3 receptor
09/12/2008WO2008109179A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008109178A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008109056A1 Sulfonylated heterocycles useful for modulation of the progesterone receptor
09/12/2008WO2008108729A1 Novel 2-heteroaryl substituted indoles 695
09/12/2008WO2008108517A2 Piperazinyl-propyl-pyrazole derivatives as dopamine d4 receptor antagonists, and pharmaceutical compositions containing the same
09/12/2008WO2008108486A1 1-biarylazetidinone derivatives
09/12/2008WO2008108380A2 Pyrrole compounds
09/12/2008WO2008107544A1 Derivatives of n-(heteroaryl)-1-heteroaryl-1h-indol-2-carboxamids, preparation thereof and therapeutic use thereof
09/12/2008WO2008107480A1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators